About us

Dianosic designs transformative intranasal solutions changing physicians experience and supporting a rapid return of patients to daily life activities.

Our history


  • Dianosic enters clinical stage in 2024 and accelerates its internationalization.


  • Dianosic raises €4.7M to prepare for clinical trial in chronic rhinitis.
  • Launch of the new CAVI-T balloon with anti-migration feature.
  • Promising ARIS-R preclinical in vivo results.
  • Dianosic adds Central Nervous System as a new vertical and strengthens its ARIS platform.


  • Dianosic ranks in the top 10 of European Medtech startups.
  • Design of a fully functional prototype of the ARIS solution for chronic allergic rhinitis (ARIS-R)


  • Dianosic receives the SNITEM’s ‘public’s favorite’ award.
  • Successful European launch of CAVI-T post COVID pandemic.
  • Launch of digital training tools for CAVI-T.


  • Dianosic closes a first round of financing of 1.5M euros.
  • Publication of the first clinical results for CAVI-T.
  • CE marking of CAVI-T and ISO 13485 certification.


  • Dianosic becomes laureate of the prestigious I-Lab 2019 innovation contest.


  • Dianosic relocates to the city of Strasbourg.


  • Development of the CAVI-T asymmetric intranasal balloon, a minimally-invasive solution to improve the treatment of epistaxis.
  • The Active Resorbable Intranasal Scaffold (ARIS) development program starts in rhinitis and sinusitis.


  • Marc Augustin (Chairman), Philippe Bastide (CEO), and Pr. Christian Debry (ENT surgeon) create Dianosic in Paris to tackle unmet needs in otorhinolaryngology (ENT) / Respiratory diseases, including chronic allergic rhinitis, chronic rhinosinusitis and epistaxis.
Our mission and ambitions

Dianosic's Commitment to Enhancing respiratory care

Ear Nose and Throat (ENT) conditions are the leading cause of physicians’ visits. There is significant room for improvement to address unmet clinical needs. Dianosic collaborates with healthcare professionals in order to provide advanced ENT solutions that will change patients’ lives in chronic rhinitis, chronic rhinosinusitis and intranasal bleeding (epistaxis). The company strives for:

Maximize patients quality of life, supporting a rapid return to daily life activities.

Optimize efficacy and safety through low dose, targeted drug delivery.

Reduce hospitalization time and frequency.

Leverage our intranasal drug delivery solutions to treat central nervous system diseases.

 Transformative intranasal solutions  Transformative intranasal solutions
 Transformative intranasal solutions  Transformative intranasal solutions
Dianosic's future : A paradigm shift with transformative innovations

Discover our programs: ARIS-R, ARIS-S and more

Dianosic develops a platform of Active Resorbable Intranasal Scaffolds (ARIS) aiming at delivering a targeted, reduced dose of drug to the nasal cavity with an “insert and forget” solution. ARIS provides a long term, sustained-release treatment revolutionizing the management of chronic diseases such as rhinitis and rhinosinusitis The innovative technology of the ARIS platform is highly scalable and promising in the field of Central Nervous System, leveraging the Nose-To-Brain concept in schizophrenia, Parkinson, etc.

Our team

Qualified team with complementary profiles

Marc Augustin Chairman / Founder
  • Seasoned entrepreneur
  • >20 years of experience in Finance and International Development (Stellantis, IBM)
  • Member of the executive committee of the health insurancel company UNEO
  • Merger Acquisition / fundraising advisor (ACM partners)
  • Linkedin account: https://bit.ly/3EvE9u1
Philippe Bastide CEO/ Founder
  • > 20 years of experience in Medtech and Pharma (Pfizer, Johnson & Johnson, Livanova)
  • Business Unit Lead at Acclarent (ENT Division of Johnson & Johnson)
  • Expertise in Market Access (pricing & reimbursement), Business Development and Professional Education
  • Linkedin account: https://bit.ly/3sRamJv
Emilie Fournier CSO - Chief Scientific Officer
  • 10 years' experience in medical devices and pharmaceuticals (Roche)
  • Expertise in quality management & regulatory affairs
  • Doctorate in Biology from the University of Strasbourg (CIFRE SANOFI)
  • Linkedin account: https://bit.ly/44RT6l2
Eric Le Goff CMC Director
  • 14 years of experience in pharmaceutical development, generics, orphan drugs and combination products
  • CMC Regulatory Project Management invariuous companies (INNOTHERA, NOVARTIS, OT4B )
  • Expertise in product development and analytical chemistry
  • Linkedin account: https://bit.ly/44GfrSh
Khadija Elhabazi QA & RA
  • Quality, Regulatory and Clinical Operations Engineer
  • 10 years' experience in research projects (University of Strasbourg)
  • Expertise in in vivo studies
  • PhD in Pharmacology + Diploma in Clinical Research
  • Linkedin account: https://bit.ly/3sQRomk
Victor Moreau R&D Engineer
  • Healthcare engineer (Master's degree in healthcare engineering, medical devices option, Montpellier, DEDIENNE SANTÉ)
  • Expertise in medical device (or healthcare product) design
  • Specialized in biodegradable polymers and active ingredient release
  • Linkedin account: https://bit.ly/3LfIgOD
Pedro Costa Campos COO - Chief Operating Officer
  • Over 20 years' career in the healthcare industry
  • Solid experience in general management, operational strategy, business development, marketing and sales management at international level, across regions (Johnson & Johnson).
  • Linkedin account: https://bit.ly/3EvE9u1
Hamed Moghadam Business development
  • 17 years' experience in medical devices and pharmaceuticals (Johnson & Johnson, Medtronic, Boston Scientific)
  • Regional Sales Manager Acclarent (Johnson & Johnson)
  • Expertise in Product Launch, Business development, Strategy
  • Linkedin account: https://bit.ly/3Zbn0PD
Romain Alberico Marketing & Sales Consultant
  • 15+ years of experience in the field of Medtech and he held different Sales and Global Marketing positions at Boston Scientific, LivaNova and, more recently, SuperSonic Imagine
  • Strong appetite for innovative marketing and sales approaches
  • Linkedin account: https://bit.ly/464yWoW
Marie Lahaye Digital project Manager
  • Expertise in marketing and digital communication
  • Specialized in brand content and web content creation
  • Linkedin account: https://bit.ly/45Ge9YJ
Ugo Lebrun Marketing assistant
  • Diverse international experience
  • Advanced English for effective communication
  • Linkedin account: https://bit.ly/45Z2NyU
Jean-Charles Vignole Sales
  • Student at ESSCA business school, Master international Business / Marketing
  • Professional experience in the Medtech world (Johnson & Johnson)
  • Linkedin account: https://bit.ly/3ZgllbS
Nathalie Stiegler Office Manager
  • More than 25 years' experience as an office manager
  • Expertise in organizational, HR and financial administration
  • Part-time Office Manager in several innovative start-ups in Strasbourg
  • Linkedin account: https://bit.ly/3Re5acP
Our partners

We built a solid network of partners to support company funding and growth.

We are backed by Business Angels, a leading crowdfunding platform (Wiseed), the Fondation force, BPI, Banque Populaire and Caisse d’Epargne Grand Est. Since inception, the support of Region Grand Est, Quest for Health, Biovalley France, Conectus and the Eurometropole has been of paramount importance.

To learn more about our current projects, long-term strategy and partners, please visit our “News & partners” page. Join us and be part of the Dianosic adventure.